Compare-Acute Sub-Study: Natural History of Non-Culprit Lesions in MI

The aim of this study was to determine the prognostic value of fractional flow reserve (FFR) of non-culprit lesions in STEMI patients. 

Sub-estudio del Compare-Acute: Historia natural de las lesiones no culpables del infarto

We analyzed data of all Compare-Acute patients (Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD) after PCI, from lesions assessed with FFR and treated medically.  The treating cardiologists were blind to FFR values. 

Primary end point was a The primary endpoint was the composite of cardiovascular mortality, target vessel-related (non-IRA with FFR measurement at primary percutaneous coronary intervention) nonfatal MI, and target vessel revascularization: major adverse cardiac events at 24 months. 

It included 751 patients (963 vessels). Non-culprit lesions that were not revascularized showed significantly lower FFR (0.78 vs. 0.84; p<0.001). 

This difference was significative in all vessels.


Read also: Bleeding and Cardiogenic Shock: An “Unholy Alliance”?


Mean FFR of original non- culprit lesions that later presented as MI also resulted lower (0.79 vs. 0.84; p=0.016).

All data point to a significantly higher events rate (p<0.001) in the lowest tertile of FFR (<0.80) compared against the two higher tertiles (0.80 to 0.87 and >0.88).

This phenomenon has been seen in previous studies. We should get rid of this idea of FFR provides a binary cutoff value around 0.8 and rather understand these results as a continuum of variables.  


Read also: COMPARE-ACUTE: FFR-Guided Non-Culprit Vessel Revascularization in Primary Angioplasty.


In any given lesion, the closer to 0.8, the higher the chances of these lesions evolving with events. This increase in bad odds is not linear, but rather shoots up disproportionally the closer we get to 0.8.

Conclusion

In patients with ST elevation MI and multivessel disease undergoing medical treatment in non-culprit lesions after successful primary PCI, there is a non-linear and inverse correlation between FFR values in non-culprit lesions and events. 

It is important to highlight there is worse prognosis around the 0.8 cutoff value.

Original Title: The Natural History of Nonculprit Lesions in STEMI. An FFR Substudy of the Compare-Acute Trial.

Reference: Zsolt Piróth et al. J Am Coll Cardiol Intv 2020;13:954–61.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these...

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Coronary perforations during PCI are one of the most dreaded complications in interventional cardiology, especially in bifurcations. Though rate, this critical situation requires an...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...